Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rama Al Hamed"'
Autor:
Razan Mohty, Rama Al Hamed, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Amer Zeidan, Mohamad Mohty
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-16 (2022)
Abstract Myelodysplastic syndromes (MDS) are a heterogeneous clonal disease of myeloid neoplasms characterized by ineffective hematopoiesis, variable degree of cytopenias, and an increased risk of progression to acute myeloid leukemia (AML). Molecula
Externí odkaz:
https://doaj.org/article/12dfeeb36de342abb9dc383635ac2ca2
Autor:
Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, Ali Bazarbachi, Jean-Luc Harousseau, Mohamad Mohty
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 3, Pp 1-8 (2022)
Abstract The current standard of care model for newly diagnosed fit multiple myeloma (NDMM) patients is the sequential treatment of induction, high dose melphalan, autologous stem cell transplantation (ASCT), and maintenance. Adequate induction is re
Externí odkaz:
https://doaj.org/article/a9fde50dfe9f4bd3bae2643256c97f11
Autor:
Rama Al Hamed, Myriam Labopin, Etienne Daguindau, Riitta Niittyvuopio, Anne Huynh, Gerard Socié, Micha Srour, Jean Henri Bourhis, Nicolaus Kröger, Eleni Tholouli, Goda Choi, Xavier Poiré, Hans Martin, Marie‐Thérèse Rubio, Pavel Jindra, Didier Blaise, Dietrich Beelen, Hélène Labussière‐Wallet, Arnon Nagler, Ali Bazarbachi, Mohamad Mohty
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1068-1080 (2022)
Abstract Nucleophosmin‐1 (NPM1) mutations in acute myeloid leukemia (AML) confer a survival advantage in the absence of FLT3‐internal tandem duplication (FLT3‐ITD). Here, we investigated the main predictors of outcome after allogeneic hematopoi
Externí odkaz:
https://doaj.org/article/0e831c93c66b43d4923f0677465fefd9
Autor:
Razan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, Malvi Savani, Rama Al Hamed, Ali Bazarbachi, Mohamad Mohty
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-10 (2021)
Abstract Hodgkin lymphoma is a highly curable disease. Although most patients achieve complete response following frontline therapy, key unmet clinical needs remain including relapsed/refractory disease, treatment-related morbidity, impaired quality
Externí odkaz:
https://doaj.org/article/e64accd26ef44d47b4d3158c1ea5c9ba
Autor:
Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau, Mohamad Mohty
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-13 (2021)
Abstract Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell (PC) clone and the secretion of unstable immunoglobulin-free ligh
Externí odkaz:
https://doaj.org/article/b5d7840b9e4049a1afab39c91584966b
Publikováno v:
Therapeutic Advances in Hematology, Vol 10 (2019)
FMS-like tyrosine kinase 3 ( FLT3 ) mutations are one of the most frequently encountered genetic alterations in acute myeloid leukemia (AML), and are generally associated with unfavorable outcomes. Several tools are currently available to provide an
Externí odkaz:
https://doaj.org/article/1d5ffd8f31584cd2af83d1774ba71136
Autor:
Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Sindhu Vikash, Karun Neupane, Eleftheria Atalla, Astha Thakkar, Shafia Rahman, Urvi Shah, Diego Adrianzen-Herrera, Ryann Quinn, Sumaira Zareef, Emma Rabinovich, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend-Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Liza Bachier-Rodriguez, Nishi Shah, Dennis Cooper, Amit Verma, Bihui Hilda Ye, Murali Janakiram, Roberto Alejandro Sica
Publikováno v:
Clinical Hematology International.
Adult T-cell leukemia/lymphoma (ATLL) remains challenging to treat and has dismal outcome. Allogeneic stem-cell transplantation (allo-SCT) has promising results, but data remain scarce. In this single-center retrospective analysis of 100 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eca364ac5227d8e77b0b43b8d352d4c
https://doi.org/10.1007/s44228-023-00032-y
https://doi.org/10.1007/s44228-023-00032-y
Autor:
Abdul-Hamid Bazarbachi, Daniel K. Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Astha Thakkar, Shafia Rahman, Urvi A Shah, Diego Adrianzen Herrera, Ryann Quinn, Sumaira Zareef, Emma Rabinovich, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Dennis Cooper, Ira Braunschweig, Amit Verma, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica
Publikováno v:
Blood. 140:662-664
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f8adf4aec1a0c6e3e528472a0cd0c23
https://doi.org/10.1182/blood-2022-170332
https://doi.org/10.1182/blood-2022-170332
Autor:
Tanim Jain, Abdul-Hamid Bazarbachi, Emma Rabinovich, Ahmed Abbasi, Kith Pradhan, Daniel K. Reef, Ryann Quinn, Hiba Narvel, Riya Patel, Rama Al Hamed, Astha Thakkar, Shafia Rahman, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Xingxing Zang, Kira Gritsman, Ulrich G. Steidl, Mendel Goldfinger, Margaret McCort, Yoram Puius, Rachel Bartash, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Marina Konopleva, Christopher Nishimura, Dennis Cooper, Ira Braunschweig, Amit Verma, R. Alejandro Sica
Publikováno v:
Blood. 140:13225-13227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30ef5faca85999d03b36ffd568b11daa
https://doi.org/10.1182/blood-2022-170633
https://doi.org/10.1182/blood-2022-170633
Autor:
Florent Malard, Jean-Luc Harousseau, Ali Bazarbachi, Abdul Hamid Bazarbachi, Mohamad Mohty, Rama Al Hamed
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 5, Pp 1-13 (2021)
Blood Cancer Journal
Blood Cancer Journal, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩
Blood Cancer Journal, Nature Publishing Group, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩
Blood Cancer Journal
Blood Cancer Journal, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩
Blood Cancer Journal, Nature Publishing Group, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩
Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a bone-marrow-residing plasma cell (PC) clone and the secretion of unstable immunoglobulin-free light chains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbd75f8f297630e13fe3a2380be1cd1
https://doaj.org/article/b5d7840b9e4049a1afab39c91584966b
https://doaj.org/article/b5d7840b9e4049a1afab39c91584966b